2m 2m 2m 2m 2m 2m 2m
Anika Therapeuti (ANIK)
NASDAQ
$19.12-$0.24 (-1.24%)
Price as of Oct 02, 2026 7:30 PM EDT- $259.1MMarket Cap
- 112.28%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Anika Therapeuti (ANIK)
$19.12-$0.24 (-1.24%)
ANIK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $19.36 | ||
Change | -$0.30 (-1.53%) | ||
Open | $19.55 | ||
High | $19.97 | ||
Low | $19.09 | ||
Previous Close | $19.66 | ||
Volume | 111,909 | ||
30-Day Average Volume | 79,609 | ||
1-Week Change | -4.30% | ||
1-Month Change | -8.29% | ||
1-Year Change | 112.28% | ||
3-Year Change | 3.92% | ||
5-Year Change | -55.26% | ||
Fundamentals | |||
Shares Outstanding | 13.4M | ||
Total Assets | $183.5M | ||
Market Cap | $259.1M | ||
Enterprise Value | $220.7M | ||
Period: QTR TTM FY | |||
Revenue | $32.6M | ||
Net Income | $3.3M | ||
Free Cash Flow | -$2.1M | ||
EBIT | $3.4M | ||
EBITDA | $4.9M | ||
Net Working Capital | $77.0M | ||
EPS | $0.24 | ||
Enterprise Value/EBITDA | 45 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 2 | ||
P/E | 81 | ||
PEG | 0 | ||
Price/Free Cash Flow | -121 | ||
Price/Operating Cash Flow | -379 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue